Literature DB >> 2986955

Characterization and subcellular distribution of somatogenic receptor in rat liver.

B Husman, G Andersson, G Norstedt, J A Gustafsson.   

Abstract

Binding of [125I]iodobovine GH [( 125I]iodo-bGH) to rat liver microsomes and Golgi/endosomal fractions isolated from male and female rats has been characterized. Binding of bGH to a pure somatogenic site was suggested by the finding that 50% inhibition of [125I]iodo-bGH binding required 5-130 ng bGH, rGH, or hGH/incubation, while around 500 ng rat PRL/incubation were needed to obtain the same effect. Binding of [125I]iodo-bGH to microsomes and Golgi/endosomes was time, temperature, and protein dependent. Maximal specific binding occurred at 15-16 and 15-20 h at 22 C in Golgi and microsomal membranes, respectively. Subcellular distribution studies demonstrated in the Golgi/endosomal fractions compared to the total particulate fraction, while residual microsomes devoid of Golgi/endosomal-derived components were approximately 2-fold enriched. Low levels of somatogenic receptors were detected in lysosome-enriched fractions. Removal of endogenous ligand by treating Golgi/endosomal membranes with 3 M MgCl2 increased specific binding of bGH about 2- to 3-fold. These results indicate that approximately 50% of specific somatogenic binding sites in the low density fractions represent internalized ligand-receptor complexes. The level of rat liver somatogenic receptors did not show a pronounced sex differentiation; however, an endocrine dependence of somatogenic receptor levels is suggested by the finding that livers from rats in the late stages of pregnancy had a level of somatogenic receptors exceeding that of nonpregnant rats.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986955     DOI: 10.1210/endo-116-6-2605

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Expression of growth hormone receptor and its mRNA in hepatic cirrhosis.

Authors:  Hong-Tao Wang; Shuang Chen; Jie Wang; Qing-Jia Ou; Chao Liu; Shu-Sen Zheng; Mei-Hai Deng; Xiao-Ping Liu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Protective effects of recombinant human growth hormone on cirrhotic rats.

Authors:  Shuang Chen; Hong-Tao Wang; Bin Yang; Yu-Ru Fu; Qing-Jia Ou
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

3.  Lactogenic and somatogenic binding sites in intact and detergent-solubilized membrane preparations of female rat liver.

Authors:  L A Haldosén; J A Gustafsson
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

4.  Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas.

Authors:  T García-Caballero; H M Mertani; A Lambert; R Gallego; M Fraga; E Pintos; J Forteza; M Chevallier; P E Lobie; B K Vonderhaar; A Beiras; G Morel
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.925

5.  Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma.

Authors:  Xiangjun Kong; Wenyong Wu; Yan Yuan; Vijay Pandey; Zhengsheng Wu; Xuefei Lu; Weijie Zhang; Yijun Chen; Mingming Wu; Min Zhang; Gaopeng Li; Sheng Tan; Pengxu Qian; Jo K Perry; Peter E Lobie; Tao Zhu
Journal:  Oncotarget       Date:  2016-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.